Literature DB >> 17277925

Critical weight loss in head and neck cancer--prevalence and risk factors at diagnosis: an explorative study.

Harriët Jager-Wittenaar1, Pieter U Dijkstra, Arjan Vissink, Bernard F A M van der Laan, Rob P van Oort, Jan L N Roodenburg.   

Abstract

GOALS OF WORK: Critical weight loss (> or =5% in 1 month or > or =10% in 6 months) is a common phenomenon in head and neck cancer patients. It is unknown which complaints are most strongly related to critical weight loss in head and neck cancer patients at the time of diagnosis. The aim of this explorative study was to assess the prevalence of critical weight loss and to analyze risk factors for critical weight loss in head and neck cancer patients before treatment.
MATERIALS AND METHODS: Critical weight loss and factors reducing dietary intake were assessed in 447 patients referred to an ear, nose and throat clinic at the time of diagnosis. MAIN
RESULTS: In total, data of 407 patients were analyzed. Critical weight loss was present in 19% of the patients. Patients with cancer in the hypopharynx, oropharynx/oral cavity and supraglottic larynx had the highest risk for critical weight loss. Loss of appetite, dysphagia/passage difficulties and loss of taste/aversion were significantly (p < 0.05) associated with critical weight loss.
CONCLUSIONS: Already before treatment, critical weight loss is a considerable problem in head and neck cancer patients. Critical weight loss is frequently observed in patients with cancer in the hypopharynx, oropharynx/oral cavity and supraglottic larynx.

Entities:  

Mesh:

Year:  2007        PMID: 17277925     DOI: 10.1007/s00520-006-0212-9

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  31 in total

1.  Definition of terms, style, and conventions used in A.S.P.E.N. guidelines and standards.

Authors:  Daniel Teitelbaum; Peggi Guenter; Wanda H Howell; Martin E Kochevar; Julie Roth; Douglas L Seidner
Journal:  Nutr Clin Pract       Date:  2005-04       Impact factor: 3.080

2.  Percutaneous endoscopically guided gastrostomy in patients with head and neck cancer.

Authors:  R Fietkau; H Iro; D Sailer; R Sauer
Journal:  Recent Results Cancer Res       Date:  1991

3.  Serum levels of interleukin-6 in patients with primary head and neck squamous cell carcinoma.

Authors:  Frank Riedel; Inka Zaiss; Denise Herzog; Karl Götte; Ramin Naim; Karl Hörmann
Journal:  Anticancer Res       Date:  2005 Jul-Aug       Impact factor: 2.480

Review 4.  Central nervous system mechanisms contributing to the cachexia-anorexia syndrome.

Authors:  C R Plata-Salamán
Journal:  Nutrition       Date:  2000-10       Impact factor: 4.008

5.  Prevalence of malnutrition on admission to four hospitals in England. The Malnutrition Prevalence Group.

Authors:  J Edington; J Boorman; E R Durrant; A Perkins; C V Giffin; R James; J M Thomson; J C Oldroyd; J C Smith; A D Torrance; V Blackshaw; S Green; C J Hill; C Berry; C McKenzie; N Vicca; J E Ward; S J Coles
Journal:  Clin Nutr       Date:  2000-06       Impact factor: 7.324

6.  Incidence of weight loss in head and neck cancer patients on commencing radiotherapy treatment at a regional oncology centre.

Authors:  J Lees
Journal:  Eur J Cancer Care (Engl)       Date:  1999-09       Impact factor: 2.520

7.  Prophylactic gastrostomy tubes in patients undergoing intensive irradiation for cancer of the head and neck.

Authors:  J H Lee; M Machtay; L D Unger; G S Weinstein; R S Weber; A A Chalian; D I Rosenthal
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1998-08

Review 8.  Preoperative nutritional support at home in head and neck cancer patients: from nutritional benefits to the prevention of the alcohol withdrawal syndrome.

Authors:  Pauline Coti Bertrand; Marie-Astrid Piquet; Isabelle Bordier; Philippe Monnier; Michel Roulet
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2002-07       Impact factor: 4.294

Review 9.  Cancer anorexia: clinical implications, pathogenesis, and therapeutic strategies.

Authors:  Alessandro Laviano; Michael M Meguid; Filippo Rossi-Fanelli
Journal:  Lancet Oncol       Date:  2003-11       Impact factor: 41.316

10.  Nutritional status--a prognostic indicator in head and neck cancer.

Authors:  G B Brookes
Journal:  Otolaryngol Head Neck Surg       Date:  1985-02       Impact factor: 3.497

View more
  44 in total

1.  Association of oral toxicity and taste changes during hematopoietic stem cell transplantation: a preliminary study.

Authors:  Mariana Henriques Ferreira; Leticia Mello Bezinelli; Fernanda de Paula Eduardo; Roberta Marques Lopes; Andrea Z Pereira; Nelson Hamerschlack; Luciana Corrêa
Journal:  Support Care Cancer       Date:  2019-06-24       Impact factor: 3.603

2.  Dietary counselling and nutritional support in oropharyngeal cancer patients treated with radiotherapy: persistent weight loss during 1-year follow-ups.

Authors:  C P Vlooswijk; P H E van Rooij; J C Kruize; H A Schuring; A Al-Mamgani; N M de Roos
Journal:  Eur J Clin Nutr       Date:  2015-07-22       Impact factor: 4.016

3.  Factors associated with weight loss during radiotherapy in patients with stage I or II head and neck cancer.

Authors:  Alice Nourissat; Isabelle Bairati; André Fortin; Michel Gélinas; Abdenour Nabid; François Brochet; Bernard Têtu; François Meyer
Journal:  Support Care Cancer       Date:  2011-03-20       Impact factor: 3.603

4.  The head and neck symptom checklist©: an instrument to evaluate nutrition impact symptoms effect on energy intake and weight loss.

Authors:  Catherine Kubrak; Kärin Olson; Vickie E Baracos
Journal:  Support Care Cancer       Date:  2013-07-14       Impact factor: 3.603

Review 5.  The effect of prophylactic percutaneous endoscopic gastrostomy (PEG) tube placement on swallowing and swallow-related outcomes in patients undergoing radiotherapy for head and neck cancer: a systematic review.

Authors:  Stephanie M Shaw; Heather Flowers; Brian O'Sullivan; Andrew Hope; Louis W C Liu; Rosemary Martino
Journal:  Dysphagia       Date:  2015-03-04       Impact factor: 3.438

6.  NRS-2002 for pre-treatment nutritional risk screening and nutritional status assessment in head and neck cancer patients.

Authors:  Helena Orell-Kotikangas; Pia Österlund; Kauko Saarilahti; Paula Ravasco; Ursula Schwab; Antti A Mäkitie
Journal:  Support Care Cancer       Date:  2014-11-05       Impact factor: 3.603

7.  Weight loss as a prognostic factor for recurrence and survival in oropharyngeal squamous cell carcinoma patients.

Authors:  Antuani Rafael Baptistella; Klisman Drescher Hilleshein; Caroline Beal; Juliana S Brambatti; Ruggero Caron; Shaline Ferla Baptistella; Radamés Ádamo Zuquello; Carina Rossoni; Gabriel Manfro
Journal:  Mol Clin Oncol       Date:  2018-10-05

8.  Clinical predictors for reactive tube feeding in patients with advanced oropharynx cancer receiving radiotherapy ± chemotherapy.

Authors:  Belinda Vangelov; Robert I Smee
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-07-26       Impact factor: 2.503

9.  A clinical audit of the nutritional status and need for nutrition support amongst head and neck cancer patients treated with radiotherapy.

Authors:  E Jeffery; J Sherriff; C Langdon
Journal:  Australas Med J       Date:  2012-01-31

10.  Factors associated with clinical benefit from epidermal growth factor receptor inhibitors in recurrent and metastatic squamous cell carcinoma of the head and neck.

Authors:  Ezra Eddy Wyssam Cohen; Anna B Halpern; Kristen Kasza; Masha Kocherginsky; Rosalyn Williams; Everett E Vokes
Journal:  Oral Oncol       Date:  2009-07-07       Impact factor: 5.337

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.